Robeco Institutional Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Hold
66,407
– – ﹤0.01% 697
2026
Q1
$1.3M Buy
+66,407
New +$1.62M ﹤0.01% 709
2022
Q4
– Sell
-36,497
Closed -$1.03M – 943
2022
Q3
$1.03M Hold
36,497
– – ﹤0.01% 698
2022
Q2
$1.27M Buy
36,497
+2,936
+9% +$105K ﹤0.01% 675
2022
Q1
$1.21M Buy
+33,561
New +$952K ﹤0.01% 690

Other funds holding AMPH

Robeco Institutional Asset Management's AMPH Position: Q2 2026 in Review

Robeco Institutional Asset Management held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 66,407 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #697.

Robeco Institutional Asset Management first reported a position in AMPH in Q1 2022 and has held it in 5 quarters since. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Robeco Institutional Asset Management held 66,407 shares of Amphastar Pharmaceuticals worth $1.34M as of Q2 2026.
  • Robeco Institutional Asset Management left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #697 holding.
  • Robeco Institutional Asset Management first reported a position in Amphastar Pharmaceuticals in Q1 2022 and has held it in 5 quarters since.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.